It has been demonstrated that increased editing at the 3’UTR region occurs in breast cancer cells compared to in immortalized non-malignant cell lines, suggesting that there is a significant association between mRNA editing in genes related to cancer-relevant pathways and that ADAR1 plays a significant role in BC [96]. This evidence concerns the gene ADAR and breast cancer.